Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 9 of about 9 for DAVID MCCALL
Company Exchange Symbol Last price Quote change Market cap
Standard Pacific Corp. NYSE SPF 7.91 +0.05 (0.64%) 2.20B
Standard Pacific Corp., is a geographically diversified business spans many of the housing markets, including metropolitan markets in California, Florida, ...
Executive:
David J. Matlin
Town Sports International Holdings, Inc. NASDAQ CLUB 6.12 +0.11 (1.83%) 146.06M
Town Sports International Holdings, Inc. (TSI Holdings) is an owner and operator of fitness clubs in the Northeast and Mid-Atlantic regions of the United ...
Executive:
David M. Kastin
Oiltanking Partners LP NYSE OILT 45.81 +0.35 (0.77%) 3.78B
Oiltanking Partners, LP (OTLT) is engaged in the terminaling, storage and transportation of crude oil, refined petroleum products and liquefied petroleum ...
Executive:
David L. Griffis
Victory Energy Corp(NDA) OTCMKTS VYEY 0.280 +0.030 (11.96%) 8.01M
Victory Energy Corporation is an independent, growth oriented oil and natural gas company. The Company is engaged in the exploration, acquisition, ...
Executive:
David McCall
Johnston Press plc LON JPR 3.85 -0.06 (-1.53%) 203.81M
Johnston Press plc is engaged in the publishing of local and regional weekly, evening and morning newspapers; both paid-for and free in print and digital ...
Executive:
David King
Alumasc Group plc LON ALU 124.95 +0.95 (0.77%) 45.25M
The Alumasc Group plc is a supplier of premium building and precision engineering products. The principal activities of the Company are the design, ...
Executive:
David Armfield
Ariel Investments, LLC Private
Ariel Investments, founded in 1983, is the first African American-owned money management firm in the US. The company serves individual and institutional ...
Executive:
David J. Vitale
Dimerix Bioscience Ltd ASX DXBXBB
Dimerix Bioscience Ltd, formerly Dimerix Bioscience Pty Ltd, is engaged in developing and commercializing drug therapies and drug discovery tools.
Executive:
David Everett Fuller Ph.D.
Dimerix Bioscience Ltd ASX DXB
Dimerix Bioscience Ltd, formerly Dimerix Bioscience Pty Ltd, is engaged in developing and commercializing drug therapies and drug discovery tools.
Executive:
David Everett Fuller Ph.D.